Propanc Biopharma, Inc. Common Stock

PPCBNASDAQ • USD
ThemeHealthcare - Oncology›Targeted Therapy & Precision Oncology
0.64 USD
↘ 0.19 (22.60%)AT CLOSE (11:59 AM EDT)
0.63
↘ 0.00 (0.63%)
POST MARKET (AS OF 07:57 PM EDT)
Post Market
AS OF 07:57 PM EDT
0.63
↘ 0.00 (0.63%)
🔴Market: CLOSED

PPCB is currently priced at $0.65. The technical outlook is "Strong Sell" based on moving average alignment, RSI, and MACD signals. Notable factors include negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. The stock looks compelling on valuation, with multiples below sector averages across P/E, P/B, and EV/EBITDA.

Technical & fundamental data as of Sep 16, 2026.

Open?$0.85
High?$0.86
Low?$0.63
Prev. Close?$0.82
Volume?1.1M
Avg. Volume?3.6M
VWAP?$0.79
Rel. Volume?0.31x
Bid / Ask
Bid?$0.54 × 100
Ask?$0.86 × 100
Spread?$0.32
Midpoint?$0.70
Valuation & Ratios
Market Cap?1.9M
Shares Out?3.5M
Float?2.5M
Float %?71.3%
P/E Ratio?N/A
P/B Ratio?0.19
EPS?-$8.47
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Propanc Biopharma Inc is a development-stage healthcare company. It focuses on developing new cancer treatments for patients suffering from pancreatic, ovarian, and colorectal cancer. The company develops a rational, composite formulation of the anti-cancer compound, which together exert a number of effects designed to control or prevent tumors from recurring and spreading through the body. Its product, PRP, is a variation upon its novel formulation and involves proenzymes, the inactive precursors of enzymes.
Themes
Healthcare - Oncology›Targeted Therapy & Precision OncologyBiotech - Drug Development›Clinical-Stage Platforms
Employees
2
Market Cap
1.9M
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.propanc.com
Listed
2012-06-15
Address
302/6 BUTLER STREET
CAMBERWELL, VICTORIA, C3 3124
Phone: 61-03-9882-0780
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental Outlook
Loading...
Short InterestHigh
Short % of Float?13.45%High
Short Interest?336.0K
Days to Cover?1.0
Free Float2.5M
Avg Daily Volume9.1M
Settlement Date2026-08-31
Financial Health
Current Ratio?2.37Strong
Quick Ratio?2.37Strong
Cash Ratio?0.13Low
Debt/Equity?0.07Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
100/100
P/E?
N/A▾
P/B?
Peers
100
S&P
97
0.19CHEAP▾
P/S?
N/A▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-0.1CHEAP▾
EV/Sales?
N/A▾
Returns & Efficiency
ROE?
S&P
3
-196.3%WEAK▾
ROA?
S&P
3
-134.6%WEAK▾
Cash Flow & Enterprise
FCF?$-4112751
Enterprise Value?$2.1M
Fundamentals ratios updated end of day
MarketsMoversWatchlist